You are invited to the fifth lecture in the “Bridge to Industry” series:
Redefining the Boundaries of Antibody Capabilities
Speaker: Dr. Yehezkel (Hezi) Sason, VP R&D, Biolojic Design
Dr. Hezi Sason is a senior executive in the biotechnology industry and a scientist whose career has flourished at the intersection of biology, innovation, and drug development. Currently serving as Senior Vice President for Technological Research and Development at Biolojic Design, Dr. Sason leads teams developing antibody-based therapeutics for severe diseases such as cancer and autoimmune disorders.
Combining his academic background with extensive industrial experience, Dr. Sason has led multiple research programs that evolved from the lab to clinical trials. Some of these programs were acquired by international pharmaceutical companies and are now in advanced stages of human testing.
He played a key role in developing Biolojic’s unique AI-driven antibody design platform, which has significantly accelerated the company’s ability to create novel therapeutics. Throughout his journey, Dr. Sason has demonstrated a deep commitment to mentoring and inspiring the next generation of scientists, believing that the greatest breakthroughs emerge when diverse minds collaborate across disciplines.
In this talk, he will share not only the science but also the story behind the journey — how biology, technology, and teamwork can unite to save lives.
Date: Wednesday, November 19, at 13:00
Location: Biology Auditorium
Schedule:
12:30–13:00 Coffee and light refreshments – Lobby outside the auditorium
13:00–14:00 Seminar – Biology Auditorium
14:00–14:30 Open discussion with the speaker on “Bridge to Industry” – Auditorium Lobby
Join us for a fascinating journey of discovery, collaboration, and innovation!
[Click here to register]
